James E. O'Neill
Nessuna posizione attualmente
Profilo
James E.
O'Neill served as the Chief Financial & Accounting Officer at Anika Therapeutics, Inc. and as the Principal Accounting Officer & Controller at Cerulean Pharma, Inc. He obtained an undergraduate degree from Massachusetts College of Liberal Arts.
Precedenti posizioni note di James E. O'Neill
| Società | Posizione | Fine |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Direttore Finanziario/CFO | 13/05/2005 |
Cerulean Pharma, Inc.
 Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Comptroller/Controller/Auditor | - |
Formazione di James E. O'Neill
| Massachusetts College of Liberal Arts | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ANIKA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- James E. O'Neill
